Sun Pharma unit poised to buy Canadian biotech Antibe
pharmaphorum
JANUARY 19, 2025
Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and inflammation
pharmaphorum
JANUARY 19, 2025
Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and inflammation
Pharmacy Times
JANUARY 19, 2025
Presentations detail clinical trial results and drugs in the pipeline.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 19, 2025
Novo Nordisk's high-dose version of semaglutide boosts its weight-loss ability, but it still can't match its main rival in the obesity market
STAT
JANUARY 19, 2025
A next-generation form of chemotherapy from AstraZeneca and Daiichi Sankyo has won Food and Drug Administration authorization for a form of breast cancer, the first U.S. approval for a drug for which the companies have high expectations. The FDA on Friday announced it had approved the drug, to be marketed as Datroway, for certain advanced breast cancer patients.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Med Ed 101
JANUARY 19, 2025
We’ve put together this crossword puzzle on sexually transmitted infections. If more crossword puzzles interest you pertaining to pharmacology and medications, you might enjoy our pharmacy technician crossword puzzle book or NAPLEX crossword puzzle book! The answers to this crossword puzzle can be found at the end of this post! The post Can You Pass The Test?
Let's personalize your content